|
|
|
Volumn 10, Issue 56, 2001, Pages 190-191
|
|
Sevelamer - Second line treatment of hyperphosphoraemia in haemodialysis patients
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALUMINUM HYDROXYCARBONATE;
CALCIUM CARBONATE;
SEVELAMER;
VITAMIN D DERIVATIVE;
ALPHA TOCOPHEROL DEFICIENCY;
CHRONIC KIDNEY FAILURE;
DRUG CHOICE;
DRUG EFFECT;
DRUG MARKETING;
DRUG SAFETY;
HEMODIALYSIS;
HUMAN;
HYPERPHOSPHATEMIA;
NOTE;
RENAL OSTEODYSTROPHY;
RETINOL DEFICIENCY;
RISK FACTOR;
SECONDARY HYPERPARATHYROIDISM;
VITAMIN D DEFICIENCY;
VITAMIN K DEFICIENCY;
|
|
EID: 0037603086
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|